Aktis Oncology, Inc. Operating Cash Flow
Aktis Oncology, Inc. (AKTS) reported Operating Cash Flow of -$44.83 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-13.
Financial Statements › Cash Flow › Operating Activities
us-gaap:NetCashProvidedByUsedInOperatingActivities · last filed 2026-08-13
- Aktis Oncology, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-06-30 was -$20.59M.
- Aktis Oncology, Inc. net cash provided by (used in) operating activities for the quarter ending 2026-03-31 was -$24.24M.
- Aktis Oncology, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-06-30 was -$16.18M.
- Aktis Oncology, Inc. net cash provided by (used in) operating activities for the quarter ending 2025-03-31 was -$17.48M.
| Period end | Net Cash Provided by (Used in) Operating Activities 3 month | Net Cash Provided by (Used in) Operating Activities 6 month |
|---|---|---|
| 2026-06-30 | -$20.59M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$44.83M 10-Q · filed 2026-08-13 |
| 2026-03-31 | -$24.24M 10-Q · filed 2026-05-11 | |
| 2025-06-30 | -$16.18M derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-13 | -$33.66M 10-Q · filed 2026-08-13 |
| 2025-03-31 | -$17.48M 10-Q · filed 2026-05-11 |